Dr.ย Mosheย Yeshurun
MD, Board Certified Haematology
Head, Bone Marrow Transplantation Unit
corporate_fareDavidoff Center, Beilinson Hospital, Rabin Medical Center, Petah Tikva
Moshe Yeshurun
MD, Board Certified Haematology
Prof. Moshe Yeshurun is a leading Israeli haematologist specialising in bone marrow transplantation and haematopoietic stem cell transplantation, based at the Bone Marrow Transplantation Unit, Institute of Haematology, Davidoff Center, Beilinson Hospital, Rabin Medical Center in Petah Tikva, Israel. He is also a Professor in the Faculty of Medicine at Tel Aviv University, with a research profile active from 1995 to present encompassing over 114 indexed outputs.
Prof. Yeshurun established the Bone Marrow Transplantation Unit at Davidoff Cancer Center, Rabin Medical Center in 2007 and has led the unit since. His clinical work focuses on allogeneic haematopoietic stem cell transplantation, graft-versus-host disease prevention and management, acute myeloid leukaemia, transplant immunology, and the long-term complications of haematopoietic cell transplantation. The unit treats haematologic malignancies, stem cell disorders, inherited blood disorders, and selected solid tumours where transplant-based care is clinically indicated. His academic contributions include principal investigator roles in clinical trials, peer-reviewed publications in international journals including Blood Advances and Nature, and an extensive body of translational transplant research. For international patients, his profile is particularly relevant for second opinions and treatment planning for leukaemia, lymphoma, myeloma, bone marrow failure, and transplant-related complications.
CancerFax can coordinate medical-report review and consultation support for international patients seeking assessment or a second opinion from Prof. Yeshurun at Rabin Medical Center, subject to hospital availability and case acceptance.
Why Consider Prof. Moshe Yeshurun?
Prof. Yeshurun combines more than 25 years of focused transplant haematology experience with an active research programme and leadership of one of Israel's major bone marrow transplant units.
Areas of Specialisation
Focused on bone marrow transplantation, allogeneic stem cell therapy, and the management of complex haematologic malignancies
Prof. Yeshurun's specialisation spans haematopoietic stem cell transplantation, graft-versus-host disease, acute myeloid leukaemia, and the management of inherited and acquired bone marrow disorders. His practice combines advanced transplant protocols with an active research programme.
Haematopoietic Stem Cell Transplantation
Comprehensive allogeneic and related transplant programmes for haematologic malignancies and bone marrow disorders.
- arrow_rightDonor selection, HLA matching, and conditioning regimen planning
- arrow_rightAllogeneic stem cell transplant for leukaemia, lymphoma, and myeloma
- arrow_rightReduced-intensity conditioning for eligible patients
- arrow_rightCombined kidney and haematopoietic stem cell transplantation for immune tolerance induction, as reflected in ClinicalTrials.gov records
- arrow_rightMultidisciplinary transplant planning in selected complex cases
Graft-Versus-Host Disease (GVHD)
Prevention, early recognition, and treatment of GVHD as a major post-transplant complication.
- arrow_rightMethotrexate-based GVHD prophylaxis with folinic acid rescue, subject of a randomised controlled study in Blood Advances
- arrow_rightCannabidiol for GVHD prevention after allogeneic HCT (clinical trial PI, NCT01385124)
- arrow_rightAcute and chronic GVHD diagnosis and treatment planning
- arrow_rightSupportive care and long-term follow-up for GVHD complications
Haematologic Malignancies
Blood cancer evaluation and treatment planning within the Davidoff Center, including transplant-eligible and transplant-ineligible pathways.
- arrow_rightAML treatment planning and risk-stratified transplant evaluation
- arrow_rightConsolidation strategies including allogeneic HSCT for eligible patients
- arrow_rightTransplant evaluation for lymphoma and myeloma requiring intensified therapy
- arrow_rightPost-transplant monitoring and complication management
Procedures Performed
Transplant-based and supportive haematology services at Davidoff Center, Rabin Medical Center
Prof. Yeshurun's practice centres on bone marrow transplantation and the full spectrum of pre- and post-transplant care, delivered within the Bone Marrow Transplantation Unit at Davidoff Center, Beilinson Hospital.
Bone Marrow & Stem Cell Transplantation
TransplantFull allogeneic transplant programme including donor evaluation, conditioning, transplant administration, and post-transplant follow-up.
GVHD Prevention & Treatment
Medical OncologyEvidence-based prophylaxis and management of graft-versus-host disease, including clinical trialโbased approaches.
Post-Transplant Monitoring & Complication Management
MonitoringLong-term follow-up, infection management, and care for transplant-related complications.
Second Opinion โ Haematology & Transplant
Second OpinionInternational and domestic second-opinion consultations for complex haematologic malignancies and transplant eligibility assessment.
Research & Publications
Over 114 peer-reviewed outputs in transplant haematology, GVHD, and haematologic malignancies
Prof. Yeshurun maintains an active academic profile at Tel Aviv University with major research themes spanning allogeneic HSCT, graft-versus-host disease, acute myeloid leukaemia, transplant immunology, and post-transplant infection. He has served as principal investigator in registered clinical trials and authored peer-reviewed work in journals including Blood Advances and Nature.
A comprehensive publication list for Prof. Moshe Yeshurun is available via Tel Aviv University's research portal and PubMed. A more detailed research summary may be provided on request.
Education & Training
Prof. Yeshurun completed his medical degree at the Sackler School of Medicine, Tel Aviv University, obtained Israeli board certifications in internal medicine and haematology, and completed specialist fellowship training in bone marrow transplantation in Paris.
Clinical Experience
Prof. Yeshurun has spent his career at Beilinson Hospital and Rabin Medical Center, progressing from senior physician roles in internal medicine and haemato-oncology to establishing and leading the Bone Marrow Transplantation Unit at Davidoff Center. He concurrently holds a professorial appointment at Tel Aviv University Faculty of Medicine.
Languages & International
Prof. Yeshurun consults in the following languages.
CancerFax can coordinate professional medical interpreter support for international patients requiring consultation in languages beyond English and Hebrew.
CancerFax can coordinate professional medical interpreter support for international patients consulting in other languages.
How CancerFax Helps You Access Dr. Moshe Yeshurun
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Moshe Yeshurun's team โ with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history โ prepared as a structured clinical summary for Dr. Moshe Yeshurun's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Moshe Yeshurun before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Moshe Yeshurun's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Moshe Yeshurun's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Moshe Yeshurun's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Prof. Moshe Yeshurun
Prof. Moshe Yeshurun specialises in haematology with a focused expertise in bone marrow transplantation and haematopoietic stem cell transplantation. He heads the Bone Marrow Transplantation Unit at Davidoff Center, Beilinson Hospital, Rabin Medical Center in Petah Tikva, Israel.
Prof. Yeshurun's unit treats haematologic malignancies including acute myeloid leukaemia, other leukaemias, lymphoma, and multiple myeloma, as well as stem cell disorders, inherited blood disorders, bone marrow failure syndromes, and selected solid tumours where transplant-based care is clinically indicated. He also manages graft-versus-host disease and post-transplant complications.
Yes. Prof. Yeshurun is the Head of the Bone Marrow Transplantation Unit at Davidoff Center, Rabin Medical Center, which he established in 2007. His programme performs allogeneic haematopoietic stem cell transplantation for eligible patients with blood cancers and bone marrow disorders.
International medical platforms list Prof. Yeshurun for patients seeking haematology and bone marrow transplant care in Israel. CancerFax can coordinate medical-record review and consultation support for international patients, subject to hospital availability and case acceptance. Prof. Yeshurun is reported to consult in English and Hebrew.
A second-opinion request can be submitted through CancerFax with the patient's pathology reports, bone marrow biopsy findings, imaging, molecular results, and treatment history. The CancerFax team will organise and prepare the documentation before coordinating with the hospital. The final consultation format and availability depend on Prof. Yeshurun's institution and schedule.
Graft-versus-host disease, or GVHD, is a serious complication that can occur after allogeneic stem cell transplantation when donor immune cells attack the recipient's tissues. Prof. Yeshurun has an extensive research and clinical focus on GVHD prevention and management, including a randomised controlled study on folinic acid rescue after methotrexate GVHD prophylaxis published in Blood Advances, and a principal investigator role in a clinical trial evaluating cannabidiol for GVHD prevention.
Submit your medical reports through CancerFax using the Send Your Reports link. The CancerFax team will review your documents, prepare the case summary, and coordinate the next steps with the hospital, subject to availability. For haematology and transplant cases, please include pathology, bone marrow findings, imaging, molecular markers, and prior treatment records where available.
Connect with Moshe Yeshurun Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.